Theracryf Plc
TCF.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £1,211 | £2,337 | £10,171 | £9,621 |
| - Cash | £2,109 | £2,004 | £5,000 | £4,510 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£898 | £333 | £5,171 | £5,111 |
| Revenue | £0 | £396 | £442 | £0 |
| % Growth | -100% | -10.4% | – | – |
| Gross Profit | -£2,112 | £385 | £429 | -£16 |
| % Margin | – | 97.2% | 97.1% | – |
| EBITDA | -£2,055 | -£3,549 | -£4,993 | -£3,153 |
| % Margin | – | -896.2% | -1,129.6% | – |
| Net Income | -£1,941 | -£3,137 | -£4,043 | -£2,730 |
| % Margin | – | -792.2% | -914.7% | – |
| EPS Diluted | -0.004 | -0.011 | -0.015 | -0.01 |
| % Growth | 68.4% | 22.4% | -48.5% | – |
| Operating Cash Flow | -£2,367 | -£2,996 | -£4,029 | -£2,560 |
| Capital Expenditures | £0 | £0 | -£1 | -£3 |
| Free Cash Flow | -£2,367 | -£2,996 | -£4,030 | -£2,563 |